Abstract
4108Background: Conventional chemotherapy (CT) for advanced pancreatic cancer (PC) is associated with dismal response rates and poor survival. Arming anti-CD3 activated T cells (ATC) with anti-CD3 ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have